Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas

Some people with certain lymphomas survive ten years cancer-free after CAR T-cell therapy, with no relapses occurring after five years.

What the study was

Journal

N Engl J Med

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.